Recombinant Human ERBB4 Protein，His

ERBB4, part of the epidermal growth factor receptor (EGFR) family, plays a pivotal role in various cellular processes, including proliferation, differentiation, and survival. Research has shown that ERBB4 is involved in numerous physiological and pathological conditions, particularly in neurological development and cancer. As a receptor tyrosine kinase, it can be activated by neuregulins and other ligands, leading to diverse downstream signaling pathways. Its unique splicing variants contribute to its functional diversity, with some isoforms promoting cell growth and others involved in apoptosis. Given its significant role in breast cancer and other malignancies, ERBB4 has emerged as a potential therapeutic target. Studies have focused on the characterization of ERBB4 recombinant proteins to better understand its molecular mechanisms and interactions. These recombinant proteins facilitate the exploration of ERBB4's structure-function relationships, enhancing our understanding of its role in tumor biology and offering insights into new treatment strategies. Researchers are particularly interested in designing inhibitors that can selectively block ERBB4 signaling to combat cancers where its dysregulation is prominent. Thus, ERBB4 recombinant protein studies form a crucial foundation for developing innovative targeted therapies and unraveling the complexities of receptor signaling in various diseases.